Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Switzerland
/
Healthcare
/
Straumann Holding
STMN
Straumann Holding
Rising Regulation And Cost Pressures Will Curb Premium Dental Demand
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 19 Analysts
Published
11 Jun 25
Updated
20 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
CHF 85.00
11.6% overvalued
intrinsic discount
20 Aug
CHF 94.90
1Y
-23.1%
7D
0.04%
Loading
1Y
-23.1%
7D
0.04%
Author's Valuation
CHF 85.0
11.6% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
CHF 85.0
11.6% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
3b
2014
2017
2020
2023
2025
2026
2028
Revenue CHF 3.1b
Earnings CHF 614.6m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
9.32%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
4.51%
Calculation
CHF 614.56m
Earnings '28
x
25.10x
PE Ratio '28
=
CHF 15.43b
Market Cap '28
CHF 15.43b
Market Cap '28
/
159.21m
No. shares '28
=
CHF 96.90
Share Price '28
CHF 96.90
Share Price '28
Discounted to 2025 @ 4.51% p.a.
=
CHF 84.89
Fair Value '25